Trial Profile
Phase II study of S-1, leucovorin plus bevacizumab in refractory colorectal cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 May 2016
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Folinic acid (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 19 Dec 2015 Status changed from recruiting to completed as per University Hospital Medical Information Network - Japan record.
- 19 Oct 2012 New trial record